Zevra Therapeutics
ZVRA60
$8.71arrow_drop_up1.61%$0.14
High Growth
ZVRA60
$8.71
arrow_drop_up1.61%| Key Stats | |
|---|---|
| Open | $8.57 |
| Prev. Close | $8.66 |
| EPS | -2.13 |
| Dividend | Non-Dividend |
| Next Earnings Date | - |
| Dividend Yield % | - |
| PE Ratio | - |
| LOW | HIGH | |
|---|---|---|
| Day Range | 8.47 | 8.85 |
| 52 Week Range | 3.89 | 9.77 |
| Ratios | |
|---|---|
| EPS | -2.13 |
| Fundamentals | |
|---|---|
| Payout Ratio | - |
| Industry average yield | 2.89% |
| Last Dividend pay date | Dec 28, 2020 |
| Dividend per share | - |
| Dividend yield forecast | - |
Stock Analysis
Technicals
Summarizing what the indicators are suggesting.
—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell
Analyst rating
An aggregate view of professional's ratings.
—Strong Buy
—Buy
—Neutral
—Sell
—Strong Sell
Stock Performance
ZVRA-
US Healthcare Sector-
US Market-
check_circle
ZVRA / Market
ZVRA exceeded the US Market which returned -0.39% over the last twenty four hours.warning
ZVRA / Healthcare Sector
ZVRA lose to the US Healthcare sector which returned 2.00% over the last twenty four hours.Zevra Therapeutics (ZVRA) Statistics
Keep an eye on Zevra Therapeutics
Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Frequently Asked Questions
help
How has Zevra Therapeutics (ZVRA) stock's performance compared to its sector and the market over the past year?
Over the past year, Zevra Therapeutics (ZVRA) has experienced a price change of . Compared to the Healthcare sector, which saw a change of 17.25%, Zevra Therapeutics has underperformed compared to its sector, indicating its relative standing within the Healthcare sector. Against the broader market's change of 24.54%, it has fallen short of the market average. This comparison highlights Zevra Therapeutics's performance relative to both its sector and the overall market over the last year.
help
What is the PE ratio of Zevra Therapeutics (ZVRA) stock?
The PE ratio for Zevra Therapeutics (ZVRA) is currently not available. This could be due to a variety of factors such as the company not having positive earnings at the moment or recent updates not being reflected.
help
What is the EPS of Zevra Therapeutics (ZVRA) stock?
The Earnings Per Share (EPS) for Zevra Therapeutics (ZVRA), calculated on a diluted basis, is -$2.13. EPS is a key indicator of a company's profitability, showing the portion of a company's profit allocated to each outstanding share of common stock.
help
What is the operating margin of Zevra Therapeutics (ZVRA) stock?
The operating margin for Zevra Therapeutics (ZVRA) is -739%. This metric represents the percentage of revenue that remains after paying for variable production costs, indicating the efficiency and profitability of the company's core business operations.
help
What is the EBITDA of Zevra Therapeutics (ZVRA) stock?
The EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) of Zevra Therapeutics (ZVRA) is -$81.22M. EBITDA is a widely used earnings metric to assess a company's operational efficiency and profitability before the impact of non-operating decisions such as financing, accounting, and tax environments.
help
How much debt does Zevra Therapeutics (ZVRA) have?
Zevra Therapeutics (ZVRA) has a total debt of $59.93M. The net debt, which accounts for cash and cash equivalents against the total debt, is $5.89M.